检索结果 - Ziming Du
- Showing 1 - 11 results of 11
-
1
-
2
-
3
-
4
Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer 由 Rumana Rashid, Giorgio Gaglia, Chen Yuan, Jia‐Ren Lin, Ziming Du, Zoltan Maliga, Denis Schapiro, Clarence Yapp, Jeremy L. Muhlich, Artem Sokolov, Peter K. Sorger, Sandro Santagata
出版 2019Artigo -
5
-
6
Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma 由 Shannon Coy, Rumana Rashid, Jia‐Ren Lin, Ziming Du, Andrew M. Donson, Todd C. Hankinson, Nicholas K. Foreman, Peter Manley, Mark W. Kieran, David A. Reardon, Peter K. Sorger, Sandro Santagata
出版 2018Artigo -
7
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors 由 Yu Mei, Wenya Linda Bi, Noah F. Greenwald, Ziming Du, Nathalie Y.R. Agar, Ursula B. Kaiser, Whitney W. Woodmansee, David A. Reardon, Gordon J. Freeman, Peter E. Fecci, Edward R. Laws, Sandro Santagata, Gavin P. Dunn, Ian F. Dunn
出版 2016Artigo -
8
Mismatch Repair Deficiency in High-Grade Meningioma: A Rare but Recurrent Event Associated With Dramatic Immune Activation and Clinical Response to PD-1 Blockade 由 Ian F. Dunn, Ziming Du, Mehdi Touat, Michael B. Sisti, Patrick Y. Wen, Renato Umeton, Adrian M. Dubuc, Matthew D. Ducar, Peter Canoll, Eric A. Severson, Julia A. Elvin, Shakti Ramkissoon, Jia‐Ren Lin, Lais Cabrera, Brenda Acevedo, Peter K. Sorger, Keith L. Ligon, Sandro Santagata, David A. Reardon
出版 2018Artigo -
9
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma 由 Ziming Du, Malak Abedalthagafi, Ayal A. Aizer, Allison McHenry, Heather H. Sun, Mark‐Anthony Bray, Omar Viramontes, Revaz Machaidze, Priscilla K. Brastianos, David A. Reardon, Ian F. Dunn, Gordon J. Freeman, Keith L. Ligon, Anne E. Carpenter, Brian M. Alexander, Nathalie Y.R. Agar, Scott J. Rodig, Elizabeth M. Bradshaw, Sandro Santagata
出版 2014Artigo -
10
Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results 由 Wenya Linda Bi, Lakshmi Nayak, David M. Meredith, Joseph Driver, Ziming Du, Samantha E. Hoffman, Yvonne Li, Eudocia Q. Lee, Rameen Beroukhim, Mikael L. Rinne, Ricardo McFaline-Figueroa, Ugonma Chukwueke, Christine McCluskey, Sarah Gaffey, Andrew D. Cherniack, Jennifer Stefanik, Lisa Doherty, Christina Taubert, Meghan Cifrino, D. C. LaFrankie, Thomas Graillon, Patrick Y. Wen, Keith L. Ligon, Ossama Al‐Mefty, Raymond Y. Huang, Alona Muzikansky, E. Antonio Chiocca, Sandro Santagata, Ian F. Dunn, David A. Reardon
出版 2021Artigo -
11
COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors 由 Xi He, Chenshu Liu, Jiangyun Peng, Zilun Li, Fang Li, Jian Wang, Ao Hu, Meixiu Peng, Kan Huang, Dongxiao Fan, Na Li, Fuchun Zhang, Weiping Cai, Xinghua Tan, Zhong-wei Hu, Xilong Deng, Yueping Li, Xiaoneng Mo, Linghua Li, Yaling Shi, Yang Li, Yuan‐Yuan Zhu, Yanrong Wu, Huichao Liang, Baolin Liao, Wenxin Hong, Ruiying He, Jiao Jiao Li, Pengle Guo, Youguang Zhuo, Lingzhai Zhao, Fengyu Hu, Wenxue Li, Wei Zhu, Zefeng Zhang, Zeling Guo, Wei Zhang, Xiqiang Hong, Weikang Cai, Lei Gu, Ziming Du, Yang Zhang, Jin Xu, Tao Zuo, Kai Deng, Li Yan, Xinwen Chen, Sifan Chen, Chunliang Lei
出版 2021Artigo
相关主题
Medicine
Biology
Cancer research
Immunology
Internal medicine
Genetics
Immune system
Immunotherapy
Antibody
Cancer
Gene
Immunofluorescence
Meningioma
Pathology
Biochemistry
Cell culture
Downregulation and upregulation
Glioma
Immune checkpoint
Immunohistochemistry
Metastasis
Nivolumab
Oncology
PD-L1
Radiation therapy
Surgery
2019-20 coronavirus outbreak
ARID1A
Adenoma
Adverse effect